Drawing based on the label description. No photo yet.
“Capecitabine tablets USP, 150 mg are light peach colored, biconvex, oblong film-coated tablets with '150' debossed on one side and 'RDY' on other side”
150 RDY pill
Pill with imprint 150 RDY is pink, rectangle, 4 mm and has been identified as Capecitabine 150 mg. It is used for breast cancer and colorectal cancer. It is supplied by Dr. Reddy's Laboratories Limited.
Capecitabine 150 mg
- Imprint
- 150 RDY
- Strength
- 150 mg
- Used for
- Breast cancer and colorectal cancer
- Color
- Pink
- Shape
- Rectangle
- Size
- 4 mm
- Score
- No score line
- Form
- Tablet
- Manufacturer
- Dr. Reddy's Laboratories Limited
- Drug class
- Nucleoside metabolic inhibitor
- NDC
- 55111-496, 55111-496-60, 55111-496-05
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Capecitabine used for?
Capecitabine is used for breast cancer and colorectal cancer.
- Medicine type
- Nucleoside metabolic inhibitor
Official uses from the US prescribing label
Colorectal Cancer
Capecitabine tablets are indicated for the:
- adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a combination chemotherapy regimen.
- perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy.
- treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen.
Breast Cancer
Capecitabine tablets are indicated for the:
- treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated.
- treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy.
Gastric, Esophageal, or Gastroesophageal Junction Cancer
Capecitabine tablets are indicated for the:
- treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regimen.
- treatment of adults with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease as a component of a combination regimen.
Pancreatic Cancer
Capecitabine tablets are indicated for the adjuvant treatment of adults with pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.
From the FDA-approved label on DailyMed (published Jul 22, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows 150 and the other side shows RDY.
- It is pink, rectangle, 4 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Capecitabine
Inactive: Anhydrous Lactose, Croscarmellose Sodium, Hypromellose 2910 (6 Mpa.s), Microcrystalline Cellulose, Magnesium Stearate, Talc, Titanium Dioxide, Ferric Oxide Yellow, Ferric Oxide Red
Other Capecitabine pills
-
191 77
Capecitabine 500 mg
Orange, capsule, 16 mm
Used for breast cancer and colorectal cancer
- XELODA 150 Capecitabine 150 mg Pink, oval, 11 mm Used for breast cancer and colorectal cancer
- CAP 150 Capecitabine 150 mg Pink, capsule, 11 mm Used for breast cancer and colorectal cancer
- C150 Capecitabine 150 mg Pink, capsule, 11 mm Used for breast cancer and colorectal cancer
- 150 Capecitabine 150 mg Pink, oval, 11 mm Used for breast cancer and colorectal cancer
- C 150 Capecitabine 150 mg Orange, capsule, 11 mm Used for breast cancer and colorectal cancer
- C150 Capecitabine 150 mg Pink, capsule, 11 mm Used for breast cancer and colorectal cancer
- A015 Capecitabine 150 mg Pink, oval, 11 mm Used for breast cancer and colorectal cancer